… in elderly patients to motivate the increased risks of toxicity … with adjuvant therapy, who
make up the majority of stage II … regimens becoming the reference treatment in colon cancer …

… -, or FOLFIRINOX-based chemotherapy regimens, suggesting a … Although grade 3 or
higher hematologic toxicities occurred … , elderly patients are at increased risk of chemotherapy-…

… the use of adjuvant chemotherapy for stage III colon cancer … A greater toxicity of chemotherapy
and radiotherapy in older … frequency and severity of comorbidity among older patients. …

… termination of chemotherapy due to oxaliplatin toxicity, which … colon cancer patients of
Caucasian race, age 18 or older, … The adjuvant chemotherapy included regimens with oxaliplatin …

… dose intensity was somewhat inferior in the older age group … FOLFOX regimens with more
grade ≥3 hematological toxicity (… chemotherapy appears to be safe with manageable toxicities …

… with neoadjuvant or adjuvant chemotherapy were prospectively … , and chemotherapy regimens.
A tool that accounts for … , dose delays, reduced dose intensity, and hospitalizations. These …

… in any stage; initiation of a new chemotherapy regimen (with/without … Chemotherapy intensity
for the first cycle of treatment was … to toxicity differences among chemotherapy regimens. …

… as the occurrence of chemotherapy toxicity grade 3 to 5, … tumor type and chemotherapy
regimen. Studies which included … an association between comorbidity and chemotherapy toxicity. …

… to chemotherapy, and depending on the degree of severity and clinical … In the elderly, the
effect of age on the toxicity of these drugs … In a phase III trial, it was reported that after 8 weeks of …

… of adjuvant chemotherapy in older patients with stage II or III … to severity of illness, social
supports, and environment [23]. … dataset to identify specific drugs. Furthermore, oxaliplatin only …